TY  - JOUR
AU  - Kwon, M
AU  - Bautista, G
AU  - Balsalobre, P
AU  - Sánchez-Ortega, I
AU  - Montesinos, P
AU  - Bermúdez, A
AU  - de Laiglesia, A
AU  - Herrera, P
AU  - Martin, C
AU  - Humala, K
AU  - Zabalza, A
AU  - Torres, M
AU  - Bento, L
AU  - Corral, L L
AU  - Heras, I
AU  - Serrano, D
AU  - Buño, I
AU  - Anguita, J
AU  - Regidor, C
AU  - Duarte, R
AU  - Cabrera, R
AU  - Gayoso, J
AU  - Diez-Martin, J L
PY  - 2017
DO  - 10.1038/bmt.2017.36
UR  - http://hdl.handle.net/10668/11009
T2  - Bone marrow transplantation
AB  - For patients with AML, the best alternative donor remains to be defined. We analyze outcomes of patients who underwent myeloablative umbilical cord blood or haploidentical hemopoietic stem cell transplantation (HSCT) in Spain. Fifty-one patients...
LA  - en
KW  - Adolescent
KW  - Adult
KW  - Aged
KW  - Cord Blood Stem Cell Transplantation
KW  - Cyclophosphamide
KW  - Disease-Free Survival
KW  - Female
KW  - Graft Survival
KW  - Graft vs Host Disease
KW  - Humans
KW  - Leukemia, Myeloid, Acute
KW  - Male
KW  - Middle Aged
KW  - Survival Rate
KW  - Transplantation Conditioning
KW  - Transplantation, Haploidentical
KW  - Young Adult
TI  - Haplo-Cord transplantation compared to haploidentical transplantation with post-transplant cyclophosphamide in patients with AML.
TY  - research article
VL  - 52
ER  -